NCT07819981

Brief Summary

This clinical trial evaluates whether a prehabilitation program is feasible for breast cancer patients receiving neoadjuvant systemic treatment before surgery. Many people with breast cancer have problems during and after treatment. These issues can make daily activities harder and make it harder for a person to enjoy daily life. Some people with breast cancer already have other health problems, like joint pain or nerve problems, which can make these symptoms worse. Research shows that being stronger and more active before and during treatment may help people do better during cancer care and recover more easily. However, many patients do not get this type of support early enough. Prehabilitation is a program that helps patients get ready for cancer treatment and surgery. It may include help with medical care, exercise, food and nutrition, and mental health. The goal is to help patients stay as strong and healthy as possible before surgery. Starting prehabilitation during neoadjuvant systemic treatment before surgery may help breast cancer patients feel better, stay stronger and recover more easily during treatment.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
29mo left

Started Feb 2027

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 18, 2026

Completed
28 days until next milestone

First Posted

Study publicly available on registry

September 15, 2026

Completed
5 months until next milestone

Study Start

First participant enrolled

February 24, 2027

Expected
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 24, 2029

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 24, 2029

Last Updated

September 15, 2026

Status Verified

September 1, 2026

Enrollment Period

2.4 years

First QC Date

August 18, 2026

Last Update Submit

September 11, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Adherence (feasibility)

    Feasibility of exercise will be determined by participant adherence to the prescribed exercise for the evaluable preoperative study period with goal of adherence of \> 70% for \> 70% of the preoperative time period. Adherence is defined as a ratio of completed versus planned exercise amount (90 minutes per week of moderate intensity aerobic exercise when on neoadjuvant systemic treatment (NST), 150 minutes per week when off NST, and 2 times per week resistance exercise), averaged between the types of exercise. Feasibility of nutrition and mind/spirit practice will also be determined based on participant adherence (\> 70% of enrolled patients during the preoperative time period).

    Up to day 168

Secondary Outcomes (16)

  • Six minute walk test

    At baseline, day 42, day 84, day 126, at pre-operative visit, and post-operative visit (21-35 days after surgery [approximately day 168])

  • Duke Activity Status Index

    At baseline, day 42, day 84, day 126, at pre-operative visit, and post-operative visit (21-35 days after surgery [approximately day 168])

  • 30-second sit to stand

    At baseline, day 42, day 84, day 126, at pre-operative visit, and post-operative visit (21-35 days after surgery [approximately day 168])

  • Short physical performance battery

    At baseline, day 42, day 84, day 126, at pre-operative visit, and post-operative visit (21-35 days after surgery [approximately day 168])

  • Patient Reported Outcomes Measurement Information System Cancer Function Brief 3-dimensional Profile

    At baseline, day 42, day 84, day 126, at pre-operative visit, and post-operative visit (21-35 days after surgery [approximately day 168])

  • +11 more secondary outcomes

Study Arms (1)

Supportive care (prehabilitation)

EXPERIMENTAL

See Detailed Description.

Other: Aerobic ExerciseProcedure: Bioelectric Impedance AnalysisOther: ConsultationOther: Educational InterventionOther: Electronic Health Record ReviewOther: Nutritional InterventionOther: Physical Performance TestingBehavioral: Psychosocial CareOther: Questionnaire AdministrationOther: ReferralOther: Resistance TrainingProcedure: Spiritual TherapyProcedure: Tailored Intervention

Interventions

Participate in aerobic exercise

Also known as: Aerobic Activity
Supportive care (prehabilitation)

Ancillary studies

Also known as: BIA, Bioelectric Impedance, Bioelectric Impedance Test, Bioelectrical Impedance Analysis, Bioimpedance Analysis
Supportive care (prehabilitation)

Attend physiatry consultation

Also known as: Consult
Supportive care (prehabilitation)

Receive prehabilitation education

Also known as: Education for Intervention, Intervention by Education, Intervention through Education, Intervention, Educational
Supportive care (prehabilitation)

Ancillary studies

Supportive care (prehabilitation)

Receive nutritional guidance

Supportive care (prehabilitation)

Ancillary studies

Also known as: Physical Fitness Testing, Physical Function Testing
Supportive care (prehabilitation)

Receive psychospiritual care

Also known as: Psychosocial Support
Supportive care (prehabilitation)

Ancillary studies

Supportive care (prehabilitation)

Receive referral(s)

Also known as: Referred
Supportive care (prehabilitation)

Participate in resistance exercise

Also known as: Strength Training
Supportive care (prehabilitation)

Receive psychospiritual care

Supportive care (prehabilitation)

Receive tailored prescriptions and recommendations

Supportive care (prehabilitation)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Documented informed consent of the participant and/or legally authorized representative
  • Willingness to comply with a physiatry consultation, start a tailored training program, and follow-up assessments
  • Age: \>= 18 years
  • Able to read and write in English
  • A diagnosis of breast cancer planned for curative intent neoadjuvant systemic treatment (NST) with a goal of breast cancer surgery
  • Plan to start NST at City of Hope Orange County
  • Willingness to complete the Healthcare Team Feedback Survey
  • \> 18 years old
  • Physicians, advanced practice providers, nurses, medical assistants, rehabilitation therapists, social workers, dietitians, mental health professionals, and other clinical staff who interact with study participants in the course of routine care

You may not qualify if:

  • Current or planned cancer treatment for a second cancer not of breast origin
  • Clinically significant uncontrolled illness limiting participation with the research intervention and assessments
  • Cancer with distant metastases
  • Other active malignancy
  • Pregnant or breastfeeding
  • Physician judgment (based on information gathered during consult visit) of medical instability including conditions such as unstable cardiopulmonary status, recent embolism (\< 4 weeks), suspected or known dissecting aneurysm, severe hypertension (resting blood pressure \> 180/110), chronic infectious disease, uncontrolled metabolic disease (e.g. diabetes with ketosis), active seizure, mental/physical impairments limiting safe exercise, or sepsis
  • Meeting or exceeding exercise guidelines over the last one month, based on the responses from the Godin Leisure-Time Physical Activity and Exercise Intent Questionnaire
  • Started second cycle before the physiatry consult
  • Inability to independently follow instructions for study assessments for any reason such as mental incapacitation or significant emotional or psychological disorder that, in the opinion of the investigators, precludes study entry. (These patients may not be able to cooperate with the prehabilitation interventions or with the data collection process.)
  • Unable to independently answer questionnaires in English or provide informed consent for any reason
  • Healthcare workers who do not interact with study participants and therefore cannot provide relevant feedback

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

City of Hope Medical Center

Duarte, California, 91010, United States

Location

City of Hope at Irvine Lennar

Irvine, California, 92618, United States

Location

MeSH Terms

Conditions

Breast Neoplasms

Interventions

ExerciseReferral and ConsultationEarly Intervention, EducationalEducational StatusMethodsExercise TestPsychiatric RehabilitationResistance TrainingSpiritual Therapies

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaProfessional PracticeOrganization and AdministrationHealth Services AdministrationChild Health ServicesCommunity Health ServicesHealth ServicesHealth Care Facilities Workforce and ServicesPreventive Health ServicesSocioeconomic FactorsPopulation CharacteristicsInvestigative TechniquesHeart Function TestsDiagnostic Techniques, CardiovascularDiagnostic Techniques and ProceduresDiagnosisRespiratory Function TestsDiagnostic Techniques, Respiratory SystemErgometryRehabilitationTherapeuticsExercise TherapyAftercareContinuity of Patient CarePatient CarePhysical Therapy ModalitiesPhysical Conditioning, HumanComplementary Therapies

Study Officials

  • Jessica Cheng

    City of Hope Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 18, 2026

First Posted

September 15, 2026

Study Start (Estimated)

February 24, 2027

Primary Completion (Estimated)

July 24, 2029

Study Completion (Estimated)

July 24, 2029

Last Updated

September 15, 2026

Record last verified: 2026-09

Locations